Dynavax Technologies Corporation

10.89-0.1000-0.91%Vol 4.86M1Y Perf 221.76%
Apr 19th, 2021 16:00 DELAYED
BID10.81 ASK10.94
Open10.84 Previous Close10.99
Pre-Market- After-Market11.06
 - -  0.17 1.56%
Target Price
16.67 
Analyst Rating
Strong Buy 1.00
Potential %
53.08 
Finscreener Ranking
★★★★     53.82
Insiders Trans % 3/6/12 mo.
-100/-100/-80 
Value Ranking
     41.06
Insiders Value % 3/6/12 mo.
-100/-100/58 
Growth Ranking
★★+     49.90
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/74 
Income Ranking
 —    -
Market Cap1.23B 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
83.30 
Earnings Date
6th May 2021

Today's Price Range

10.7611.84

52W Range

3.1612.44

5 Year PE Ratio Range

-4.30-4.90

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
9.34%
1 Month
8.57%
3 Months
112.70%
6 Months
163.04%
1 Year
221.76%
3 Years
-39.73%
5 Years
-50.57%
10 Years
-60.47%

TickerPriceChg.Chg.%
DVAX10.89-0.1000-0.91
AAPL134.840.68000.51
GOOG2 302.404.64000.20
MSFT258.74-2.0000-0.77
XOM56.48-0.1800-0.32
WFC43.880.04000.09
JNJ162.690.45000.28
FB302.24-3.9400-1.29
GE13.460.07000.52
JPM152.65-0.6500-0.42
Financial StrengthValueIndustryS&P 500US Markets
2.40
3.70
0.79
3.71
-2.90
Leverage Ratio 5.80
ProfitabilityValueIndustryS&P 500US Markets
64.60
-120.70
-100.60
-6 530.10
-
RevenueValueIndustryS&P 500US Markets
35.63M
0.31
404.33
69.82
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.24-0.1441.67
Q03 2020-0.20-0.1525.00
Q02 2020-0.24-0.27-12.50
Q01 2020-0.31-0.35-12.90
Q04 2019-0.33-0.34-3.03
Q03 2019-0.40-0.49-22.50
Q02 2019-0.63-0.66-4.76
Q01 2019-0.67-0.627.46
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.0290.91Positive
6/2021 QR0.20322.22Positive
12/2021 FY0.66246.67Positive
12/2022 FY-0.350.00-
Next Report Date6th May 2021
Estimated EPS Next Report-0.02
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume4.86M
Shares Outstanding113.26M
Trades Count25.08K
Dollar Volume39.83M
Avg. Volume5.45M
Avg. Weekly Volume2.87M
Avg. Monthly Volume2.50M
Avg. Quarterly Volume5.99M

Dynavax Technologies Corporation (NASDAQ: DVAX) stock closed at 10.89 per share at the end of the most recent trading day (a -0.91% change compared to the prior day closing price) with a volume of 4.88M shares and market capitalization of 1.23B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 245 people. Dynavax Technologies Corporation CEO is Ryan Spencer.

The one-year performance of Dynavax Technologies Corporation stock is 221.76%, while year-to-date (YTD) performance is 144.72%. DVAX stock has a five-year performance of -50.57%. Its 52-week range is between 3.16 and 12.44, which gives DVAX stock a 52-week price range ratio of 83.30%

Dynavax Technologies Corporation currently has a PE ratio of -12.60, a price-to-book (PB) ratio of 21.21, a price-to-sale (PS) ratio of 35.01, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -22.90%, a ROC of -29.15% and a ROE of -222.21%. The company’s profit margin is -%, its EBITDA margin is -100.60%, and its revenue ttm is $35.63 Million , which makes it $0.31 revenue per share.

Of the last four earnings reports from Dynavax Technologies Corporation, there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.02 for the next earnings report. Dynavax Technologies Corporation’s next earnings report date is 06th May 2021.

The consensus rating of Wall Street analysts for Dynavax Technologies Corporation is Strong Buy (1), with a target price of $16.67, which is +53.08% compared to the current price. The earnings rating for Dynavax Technologies Corporation stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Dynavax Technologies Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Dynavax Technologies Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 23.62, ATR14 : 0.87, CCI20 : 190.40, Chaikin Money Flow : -0.06, MACD : 0.64, Money Flow Index : 75.26, ROC : 10.78, RSI : 61.72, STOCH (14,3) : 64.29, STOCH RSI : 0.85, UO : 50.97, Williams %R : -35.71), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Dynavax Technologies Corporation in the last 12-months were: Andrew A. F. Hack (Buy at a value of $5 000 000), Justin Burgess (Option Excercise at a value of $0), Justin Burgess (Sold 5 309 shares of value $47 003 ), Robert Janssen (Sold 144 155 shares of value $1 264 409 ), Ryan Spencer (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Dynavax Technologies Corporation

Dynavax Technologies Corp is a clinical-stage biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. It's current product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of hepatitis B and as a disease modifying therapy for asthma. Dynavax operates in the business segment the discovery and development of biopharmaceutical products. Its Toll-like Receptor Immune Modulation Platform technology play a vital role in innate immunity and subsequent adaptive immunity. Signaling through these receptors is triggered by the binding of a variety of pathogen-associated molecules and is essential to the generation of innate immunity.

CEO: Ryan Spencer

Telephone: +1 510 848-5100

Address: 2100 Powell Street, Emeryville 94608, CA, US

Number of employees: 245

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

56%44%

Bearish Bullish

53%47%

Bearish Bullish

52%48%

News

Stocktwits